Toyomedical Partners with Toyo Seikan to Tackle Excessive Salt Intake

Collaboration for Healthier Eating

In a groundbreaking initiative, Toyo Seikan Group Holdings has begun a partnership with the innovative startup Toyomedical, known for its patented Salt Offset Technology. This collaboration aims to address the pressing global health issue of excessive salt intake, particularly prevalent in today's fast-paced society.

Toyo Seikan, headquartered in Shinagawa, Tokyo, and led by President Takuji Nakamura, has been a long-time leader in packaging solutions, using its century-long expertise to venture into health-oriented projects. The company's long-term vision, titled Vision 2050: Embracing the Future, emphasizes the importance of enhancing food and health options for consumers.

Through their collaboration with Toyomedical, co-founded by President Hidenori Takeshita in Kumamoto, the two companies plan to develop practical solutions that merge taste and health. The goal is to tackle the critical problem of excessive sodium intake while also promoting sustainable living practices.

Salt Offset Technology Explained

The Salt Offset Technology created by Toyomedical works by leveraging alginates derived from seaweed to effectively counteract the effects of dietary sodium. This innovative approach transforms sodium into sodium alginate, which is less absorbable by the body. By consuming alginates alongside meals, users can enjoy their favorite dishes without worrying about excess sodium intake. This technology not only supports the retention of flavor but also facilitates sodium excretion from the body, thus improving health outcomes.

Featured products from Toyomedical include the alginate-rich supplement Delsol and the seasoning product Zero Shio, both designed to help manage sodium levels without compromising on taste. For more information, visit Toyomedical's website.

Addressing Health Challenges

As the global population ages and health consciousness rises, the challenges of excessive salt consumption are becoming increasingly critical. The decline in food satisfaction due to reduced salt is a significant concern, particularly for those needing to monitor their sodium intake. Since 2020, Toyo Seikan has been actively investing in and collaborating with startups focused on the next-generation food value chain. Their mission is to provide solutions that contribute to healthier lifestyles, in line with their Vision 2050 objectives.

Toyomedical’s technology offers hope for individuals feeling deprived by dietary restrictions, enabling them to enjoy a balanced diet without the health risks associated with excessive sodium. Recognizing the technology's potential to enhance future eating habits, Toyo Seikan has decided to invest and intensify this collaboration.

Looking Ahead

Toyo Seikan aims to leverage its existing partnerships with other startups and its extensive global network in the agri-food tech sector to support various aspects of collaboration with Toyomedical. This includes raw material development, verification support, supply chain design, and integration with existing packaging solutions.

About Toyomedical

Founded in 2013, Toyomedical prides itself on delivering a mission to ensure that neither taste nor health is sacrificed. The Kumamoto-based startup focuses on developing and promoting diverse dietary choices through its revolutionary salt offset technology. Their commitment is encapsulated in their purpose: “We explore food and health to support a smiling tomorrow.” Visit Toyomedical's website for more insights.

The OPEN UP! PROJECT

In addition to its innovative health projects, Toyo Seikan has initiated the OPEN UP! PROJECT, aimed at resolving societal issues through their extensive packaging technologies. Launched in 2019, this project continues to address various challenges impacting sustainable living.

Company Overview

Toyo Seikan is a comprehensive packaging manufacturer serving a diverse range of materials, including metal, plastic, paper, and glass. With over 19,000 employees across 44 domestic and 50 foreign subsidiaries, the group recorded a consolidated revenue of 922.5 billion yen for the fiscal year ending in March 2025. Their commitment to maximizing stakeholder value aims towards a sustainable and inclusive future. For further details, visit Toyo Seikan Group Holdings.